
Entact Bio
Entact Bio: A preclinical biotech firm innovating protein function medications with expertise in DUB biochemistry.
- 38
- Company
- Watertown, MA, USUnited States
ENTACs (enhancement-targeting chimeras) are orally available, bifunctional small molecules that enhance the function of key proteins to treat a broad range of diseases.
The company's proprietary Encompass platform is an end-to-end system for efficiently creating ENTACs. Encompass integrates biological, chemical, and computational tools to identify disease targets amenable to ENTAC intervention, select an optimal DUB, and create specific ENTACs for each target-DUB pair.
Similar Companies

Vicinitas Therapeutics
vicinitastx.com

Entrada Therapeutics
entradatx.com

Atavistik Bio
atavistikbio.com

Enanta Pharmaceuticals
enanta.com

Ensem Therapeutics
ensemtx.com

Totus Medicines
totusmedicines.com

Triana Biomedicines
trianabio.com

Dewpoint Therapeutics
dewpointx.com
Atnt
atnt-usa.com

Extend Biosciences
extendbio.com

ZielBio
zielbio.com

Ambagon Therapeutics
ambagontx.com

Abilita Bio
abilitabio.com

Exo Therapeutics

Tentarix Biotherapeutics
tentarix.com

Enveda Biosciences
enveda.com

Endevica Bio
endevicabio.com

EnClear Therapies

Eumentis Therapeutics

Enterin
enterininc.com
Quick Facts
Who are Entact Bio's competitors?
Companies similar to Entact Bio include Vicinitas Therapeutics, Entrada Therapeutics, Atavistik Bio and Enanta Pharmaceuticals.
When was Entact Bio founded?
Entact Bio was founded in 2019.
Where is Entact Bio's headquarters located?
Entact Bio's headquarters is located in Watertown, MA, US.
When was Entact Bio's last funding round?
Entact Bio's most recent funding round was for $39.9M (USD) in January 2024.
How much disclosed funding has Entact Bio raised?
As of Jan 31, 2024, Entact Bio has disclosed funding of $120.9M (USD). Undisclosed round amounts are excluded.
How many employees does Entact Bio have?
Entact Bio has 38 employees as of Feb 6, 2024.
Classification
- Industry
- Ownership
- Technology
- Geographic Exposure
- Model
- Customer
- Main Product
- Tags
- Also Known As
- Protect Therapeutics Limited
- Headquarters
- 480 Arsenal Street, Building 1, Watertown, MA 02472, United States
- SEC CIK
- 0002008244
- EIN
- 35-2729864
- signalNfxCompany
- 86508
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541500Computer Systems Design and Related Services
- 541000Professional, Scientific, and Technical Services
- 541510Computer Systems Design and Related Services
- 541511Custom Computer Programming Services
- SIC
- 7300Business Services
- 7370Computer Programming, Data Processing, And Other Computer Related
- 7371Computer Programming Services
- Industry
- —Bioinformatics Organizations
- —Biotechnology Companies
- —Medical Organizations
- —Software Companies
Show 15 more industry codes
- NAICS
- 513200Software Publishers
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 510000Information
- 620000Health Care and Social Assistance
- 513000Publishing Industries
- 541700Scientific Research and Development Services
- 513210Software Publishers
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 8000Health Services
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8040Offices And Clinics Of Other Health Practitioners
- 8730Research, Development, And Testing Services
- 7372Prepackaged Software
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
- 8731Commercial Physical and Biological Research